Posted in | News

Great Lakes Chemical and Laurel Industries Form Antimony Joint Venture

Mar 18 2004

Related Stories

Great Lakes Chemical and Laurel Industries, part of Occidental Petroleum Corp. have agreed to form a 50:50 joint venture and combine their antimony businesses.

Together then plan to develop, manufacture and market antimony-based flame retardants, synergists and catalysts.

The new joint venture will become known as GLCC Laurel LLC and should become effective by the end of April. Manufacturing operations will be consolidated into the existing operations of Great Lakes in Mexico. Laurel Industries manufacturing operations will be absorbed into this plant, and they will close their antimony oxide operation based in Texas by the end of the year.

For more information on antimony, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback